The rush to be in the club, whose members include Eminem and Paris Hilton, saw the cartoon apes price soar to $2.25m
By Claudia Cristoferi
MILAN (Reuters) -Leonardo del Vecchio's right-hand man on Monday took the reins of the 27 billion euro ($28 billion) holding company left behind by the Italian eyewear billionaire who died last week.
Del Vecchio's departure raised questions over the fate of some of his assets, in particular his stakes in financial firms Mediobanca and Generali, whose management the 87-year-old magnate had criticised.
Del Vecchio and fellow tycoon Francesco Gaetano Caltagirone in April lost out in a shareholder vote over leadership at Generali, while Mediobanca CEO Alberto Nagel's position comes up for renewal in late 2023.
Luxembourg-based holding company Delfin on Monday said it had named Del Vecchio's most trusted aide Francesco Milleri as chairman.
Milleri, 63, started as an IT consultant at Luxottica, the spectacle business Del Vecchio founded in 1961. Last year he became CEO of EssilorLuxottica after playing a key role in the negotiations that led to Luxottica's merger with French lens maker Essilor.
Following Del Vecchio's death, Milleri has also taken on the role of EssilorLuxottica's chairman.
Milleri's appointment at Delfin suggests there are no major changes in sight over Delfin's management of its assets, two people with knowledge of the matter said.
Unless they can bridge their differences, Milleri is expected to keep up the pressure on Nagel, a third person close to the matter added.
In a further sign of continuity, Delfin said its Chief Executive Romolo Bardin, another of Del Vecchio's longstanding associates, would continue in his role.
Shares in Mediobanca and Generali had suffered when Del Vecchio died due to market concerns that his heirs may cash in on the investments.
Del Vecchio had become in recent years the No.1 investor in Mediobanca with 19.4%. He was also the second-biggest shareholder in Italy's top insurer Generali, behind Mediobanca itself, with 9.8%.
He had considered further raising the Mediobanca stake before the European Central Bank made clear Delfin would have to subject itself to its oversight, a fourth person briefed on the matter said.
Del Vecchio has left his business empire to his six children, his wife Nicoletta Zampillo and her son from a previous marriage.
They now each own 12.5% of Delfin, whose main asset is the 32% stake in EssilorLuxottica, worth some 20 billion euros.
Based on Delfin's statutes, decision-making effectively requires unanimity because of the necessary 88.5% majority.
In addition to the stakes in EssilorLuxottica, Mediobanca and Generali, Delfin also owns 27% of Paris-listed Covivio and is a long-time investor in bank UniCredit with a 2% stake.
Zampillo, whom Del Vecchio remarried in 2010 after divorcing her a decade earlier, was originally expected to inherit Del Vecchio's 25% stake in Delfin.
The opening of Del Vecchio's will on Saturday showed that her son Rocco Basilico had received half of Del Vecchio's stake.
Basilico, 32, is head of wearable technologies at Luxottica.
As head of Luxottica's Californian brand Oliver Peoples, Basilico was instrumental in introducing Del Vecchio to Facebook founder Mark Zuckerberg.
The encounter led to the 2020 partnership between Facebook and EssilorLuxottica and the launch, in September 2021, of Ray-Ban Stories, smart glasses starting at $299 provided with a camera, speakers and microphones for calls and videos. ($1 = 0.9591 euros)
(Additional reporting and writing by Valentina Za; Editing by Jane Merriman and David Evans)
Former UK-based vice-president Bruce Daisley thinks Tesla boss has underestimated the complexity of his restructuring plans
The ITV share price has collapsed by nearly 40% so far in 2022. But I believe that this cheap share offers compelling value for patient investors like me. The post At 68p, the ITV share price is far too low. Here’s why! appeared first on The Motley Fool UK.
I think the best way to secure lifelong passive income is to invest regularly in dividend-paying shares, starting as soon as possible. The post I’d buy 10,300 shares of this stock for £100 in monthly passive income appeared first on The Motley Fool UK.
This FTSE 100 bank is tipped to pay above-average dividends over the medium term. But does the worsening economic backdrop undermine current forecasts? The post 6.5% yield! Can I trust the Lloyds dividend forecast through to 2023? appeared first on The Motley Fool UK.
I plan to keep buying dividend stocks in my Stocks and Shares ISA in an aim to retire rich. That's even though rates on savings accents continue to improve. The post Forget cash accounts! I’m buying dividend stocks to build long-term wealth appeared first on The Motley Fool UK.
Social media firm sets deadline for workers to name person to represent them at job consultations amid layoffs
Layoffs come after $80bn wiped off company’s market value last month amid global economic downturn
The NHS will make the life-changing technology available to every patient across England who needs it.
Dr James Fox takes a closer look at two FTSE 100 stocks trading at discounts following periods of pandemic-induced underperformance. The post 2 undervalued FTSE 100 stocks I’m buying for the recovery! appeared first on The Motley Fool UK.
The threat of recession in the euro zone and beyond, an energy supply squeeze and the eroding effect of inflation on purchasing power mean Switzerland faces difficult years ahead, Justice Minister Karin Keller-Sutter told the Neue Zuercher Zeitung. Keller-Sutter sits on the seven-member executive Federal Council. In September, the Swiss government significantly cut its economic growth forecasts, citing growing risks from a "tense energy situation and sharp price increases".
Dr James Fox explores whether AstraZeneca shares are right for his portfolio after two years of strong share-price growth. The post If I’d invested £500 in AstraZeneca shares 2 years ago, here’s how much I’d have now! appeared first on The Motley Fool UK.
Cineworld's share price has rebounded following news of a key bankruptcy settlement. Is now the time for me to buy the beaten-down UK share? The post Cineworld’s share price has soared! What should I do? appeared first on The Motley Fool UK.
A haze of negativity currently hangs over the stock market. Investors are deeply concerned about the impact of rampant inflation, rapidly rising interest rates, impending tax rises and catastrophically weak consumer confidence on corporate profitability.
A surging Rolls-Royce share price has grabbed our writer's attention. Here's why he thinks it may continue — and how he's reacting, as a shareholder. The post With the Rolls-Royce share price moving up fast, will it hit £1? appeared first on The Motley Fool UK.
GSK shares haven't recovered from August's sell-off. Roland Head asks if he should accept the risk in order to buy this FTSE 100 stock at a discount. The post FTSE 100 focus: is it the right time to buy GSK shares? appeared first on The Motley Fool UK.
A strike by Kenya Airways pilots forced nearly two dozen flight cancellations on Saturday, affecting thousands of passengers, the beleaguered national carrier said.
Shoppers will be stung by higher delivery costs this Christmas, after analysis by The Telegraph found high street stores were in some cases charging double last year's rates for online orders.
Dr James Fox explores two dividend shares that could be big winners as the UK's energy mix shifts towards renewables, such as wind power. The post 2 dividend shares for the green energy revolution! appeared first on The Motley Fool UK.
The Cineworld share price has more than tripled since it hit a lifetime low of 1.8p three months ago. But this volatile stock is a highly risky gamble! The post Why hasn’t the Cineworld share price hit zero yet? appeared first on The Motley Fool UK.
As anger builds, Dorsey says ‘I own the responsibility for why everyone is in this situation – I grew the company too quickly’